Patent ID: 6733801
Filing Date: 2004-05-11
Classification: A61K,A61P,Y10S

Abstract:
A method of using enhancing natural killer cell activity in a subject a fermented Glycine max (L.) extract comprising the steps of:(a) fermenting a mixture of an aqueous Glycine max (L.) extract, at least one lactic acid bacteria and a yeast to form a fermented liquid; (b) sterilizing said fermented liquid; (c) filtering said fermented liquid to remove particulate matter therein to form said fermented Glycine max (L.) extract; and, (d) administering said extract in a predetermined amount to a human subject in need thereof wherein the amount is effective to enhance natural killer cell activity for treating and/or reducing a susceptibility to a disease process in which there is insufficient natural killer cell (NK cell) activation to resist and/or prevail against said disease process.